Anti-human soluble fibrin antibody, hybridoma, and immunoassaying method
US5821068A · kind A · utility
11Cited by
3References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 22, 1995 |
| Grant date | Oct 13, 1998 |
| Priority date | — |
| Expiry date | Sep 22, 2015 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/75
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A monoclonal antibody that reacts with a human soluble fibrin but not with a human fibrinogen; a hybridoma that secretes the above antibody; and a method of assaying a human soluble fibrin with the above antibody. It is possible to determine the amount of soluble fibrin in the plasma of a patient specifically, readily and rapidly by agglutination and EIA without being affected by plasma fibrinogen, plasmin-degradation product of fibrinogen, fibrin fragment, and plasmin-degradation product of stabilized fibrin even without pretreating the plasma sample.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.